Expand and subsidize GLP-1 medicines
Bill Foster supports deploying and subsidizing GLP-1 medicines, including Ozempic, Wegovy and Mounjaro, as rapidly and broadly as possible for diabetes and related illnesses. The proposal is framed as part of a wider effort to support research and control long-term health care costs.
Context: The passage does not specify eligibility, subsidy terms, or how deployment would be carried out.